Azithromycin Dihydrate
Suppliers
Names
[ CAS No. ]:
117772-70-0
[ Name ]:
Azithromycin Dihydrate
[Synonym ]:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranoside dihydrate
1-Oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b η-D-xylo-hexopyranosyl]oxy]-, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-, hydrate (1:2)
N-Methyl-11-aza-10-deoxo-10-dihydroerythromycin A CP-62993
Azithromycindihydrate
1-oxa-6-azacyclopentadecan-15-one, 13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-, hydrate (1:2)
Azithromycin Dihydrate
Azithromycin (hydrate)
Chemical & Physical Properties
[ Density]:
1.18g/cm3
[ Boiling Point ]:
822.1ºC at 760mmHg
[ Melting Point ]:
113-115ºC
[ Molecular Formula ]:
C38H76N2O14
[ Molecular Weight ]:
785.015
[ Flash Point ]:
451ºC
[ Exact Mass ]:
784.529663
[ PSA ]:
198.54000
[ LogP ]:
1.71000
[ Vapour Pressure ]:
2.51E-31mmHg at 25°C
MSDS
Safety Information
[ Hazard Codes ]:
Xi
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
24/25-36/37/39
[ RIDADR ]:
NONH for all modes of transport
[ RTECS ]:
RN6960000
[ HS Code ]:
29419000
Articles
J. Chromatogr. A. 1418 , 140-9, (2015)
The fate and removal of organic micropollutants in the environment is a demanding issue evidenced by the recent European policy. This work presents an analytical method for the trace quantification of...
Biochim. Biophys. Acta 1840(9) , 2851-61, (2014)
Gram-positive bacteria in the phylum Firmicutes synthesize the low molecular weight thiol bacillithiol rather than glutathione or mycothiol. The bacillithiol transferase YfiT from Bacillus subtilis wa...
Eur. J. Drug Metab. Pharmacokinet. 39(4) , 263-76, (2014)
The purpose of this study was to evaluate the impact of structural modifications on the 15-membered macrolactone ring and/or substituents on the in vitro ADME properties and in vivo pharmacokinetic (P...